Johnson & Johnson announced that Dr. Nadja West, a retired U.S. Army lieutenant general and former U.S. Army Surgeon General has been appointed to its Board of Directors. Commenting on the appointment, Alex Gorsky, Chairman and Chief Executive Officer, Johnson & Johnson, said, “I am pleased to welcome Dr. Nadja West to Johnson & Johnson’s…
Johnson & Johnson announced it has entered into a definitive agreement to acquire Momenta Pharmaceuticals, a company that discovers and develops novel therapies for immune-mediated diseases, in an all cash transaction for approximately $6.5 billion. This acquisition provides an opportunity for the Janssen Pharmaceutical Companies of Johnson & Johnson to broaden its leadership in immune-mediated…